![]() | Up a level |
Mohammadi, E. and Shafiee, F. and Shahzamani, K. and Ranjbar, M.M. and Alibakhshi, A. and Ahangarzadeh, S. and Beikmohammadi, L. and Shariati, L. and Hooshmandi, S. and Ataei, B. and HaghjooyJavanmard, S. (2021) Corrigendum to: �Novel and emerging mutations of SARS-CoV-2: Biomedical implications� Biomed. Pharmacother. 139 (2021) 111599 (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384X), (10.1016/j.biopha.2021.111599)). Biomedicine and Pharmacotherapy, 140.
Mohammadi, E. and Shafiee, F. and Shahzamani, K. and Ranjbar, M.M. and Alibakhshi, A. and Ahangarzadeh, S. and Beikmohammadi, L. and Shariati, L. and Hooshmandi, S. and Ataei, B. and Javanmard, S.H. (2021) Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Biomedicine and Pharmacotherapy, 139.